MARC details
| 000 -LEADER |
|---|
| fixed length control field |
05434cam a22004574a 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
16053920 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20210124091449.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
100112s2011 nyua b 001 0 eng |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
|---|
| LC control number |
2010000236 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780071624428 (hardcover : alk. paper) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
0071624422 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
DNLM/DLC |
| Transcribing agency |
DLC |
| Modifying agency |
DLC |
| Description conventions |
rda |
| 050 00 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RM300 |
| Item number |
.G644 2011 |
| 082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
615.7 |
| Edition number |
22 |
| Item number |
G |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Goodman & Gilman's pharmacological basis of therapeutics. |
| 246 13 - VARYING FORM OF TITLE |
|---|
| Title proper/short title |
Goodman and Gilman's pharmacological basis of therapeutics |
| 246 13 - VARYING FORM OF TITLE |
|---|
| Title proper/short title |
Pharmacological basis of therapeutics |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
12th ed. / |
| Remainder of edition statement |
editor, Laurence L. Brunton ; associate editors, Bruce A. Chabner, Björn C. Knollmann. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
New York : |
| Name of publisher, distributor, etc |
McGraw-Hill, |
| Date of publication, distribution, etc |
2011. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
2084 p. : |
| Other physical details |
ill. (some col.) ; |
| Dimensions |
26 cm. + |
| Accompanying material |
1 computer disc (4 3/4 in.) |
| 336 ## - CONTENT TYPE |
|---|
| Source |
rdacontent |
| Content type term |
text |
| 337 ## - MEDIA TYPE |
|---|
| Source |
rdamedia |
| Media type term |
unmediated |
| 338 ## - CARRIER TYPE |
|---|
| Source |
rdacarrier |
| Carrier type term |
volume |
| 500 ## - GENERAL NOTE |
|---|
| General note |
Rev. ed. of: Goodman & Gilman's the pharmacological basis of therapeutics. 11th ed. / editor, Laurence L. Brunton. c2006. |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references and index. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Drug invention and the pharmaceutical industry --<br/>Pharmacokinetics: the dynamics of drug absorption, distribution, metabolism, and elimination --<br/>Pharmacodynamics: molecular mechanisms of drug action --<br/>Drug toxicity and poisoning --<br/>Membrane transporters and drug response --<br/>Drug metabolism --<br/>Pharmacogenetics --<br/>Neurotransmission: the autonomic and somatic motor nervous systems --<br/>Muscarinic receptor agonists and antagonists --<br/>Anticholinesterase agents --<br/>Agents acting at the neuromuscular junction and autonomic ganglia --<br/>Adrenergic agonists and antagonists --<br/>5-Hydroxytrptamine (serotonin) and dopamine --<br/>Neurotransmission and the central nervous system --<br/>Drug therapy of depression and anxiety disorders --<br/>Pharmacotherapy of psychosis and mania --<br/>Hyponotics and sedatives --<br/>--<br/>Opioids, analgesia, and pain management --<br/>General anesthetics and therapeutic gases --<br/>Local anesthetics --<br/>Pharmacotherapy of the epilepsies --<br/>Treatment of central nervous system degenerative --<br/>Ethanol and methanol --<br/>Drug addiction --<br/>Regulation of renal function and vascular volume --<br/>Renin and angiotensin --<br/>Treatment of myocardial ischemia and hypertension --<br/>Pharmacotherapy of congestive heart failure --<br/>Anti-arrhythmic drugs --<br/>Blood coagulation and anticoagulant, fibrinolytic, and antiplatelet drugs --<br/>Drug therapy for hypercholesterolemia and dyslipidemia --<br/>Histamine, bradykinin, and their antagonists --<br/>Lipid-derived autocoids: eicosanoids and platelet-activating factor --<br/>Anti-inflammatory, antipyretic, and analgesic agents; pharmacotherapy of gout --<br/>Immunosuppressants, tolerogens, and immunostimulants --<br/>Pulmonary pharmacology --<br/>Hematopoietic agents: growth factors, minerals, and vitamins --<br/>Introduction to endocrinology: the hypothalamic-pituitary axis --<br/>Thyroid and anti-thyroid drugs --<br/>Estrogens and progestins --<br/>Androgens --<br/>ACTH, adrenal steroids, and pharmacology of the adrenal cortex --<br/>Endocrine pancreas and pharmacotherapy of diabetes mellitus and hypoglycemia --<br/>Agents affecting mineral ion homeostasis and bone turnover --<br/>Pharmacotherapy of gastric acidity, peptic ulcers, and gastroesophageal reflux disease --<br/>Treatment of disorders of bowel motility and water flux; anti-emetics; agents used in biliary and pancreatic disease --<br/>Pharmacotherapy of inflammatory bowel disease --<br/>General principles of antimicrobial therapy --<br/>Chemotherapy of malaria --<br/>Chemotherapy of protozoal infections: amebiasis, giardiasis, trichomoniasis, trypanosomiasis, leishmaniasis, and other protozoal infections --<br/>Chemotherapy of helminth infections --<br/>Sulfonamides, trimethoprim-sulfamethoxazole, quinolones, and agents for urinary tract infections --<br/>Penicillins, cephalosporins, and other ß-lactam antibiotics --<br/>Aminoglycosides --<br/>Protein synthesis inhibitors and miscellaneous antibacterial agents --<br/>Chemotherapy of tuberculosis, mycobacterium avium complex disease, and leprosy --<br/>Antifungal agents --<br/>Antiviral agents (nonretroviral) --<br/>Antiretroviral agents and treatment of HIV infection --<br/>General principles of cancer chemotherapy --<br/>Cytotoxic agents --<br/>Targeted therapies: tyrosine kinase inhibitors, monoclonal antibodies, and cytokines --<br/>Natural products in cancer chemotherapy: hormones and related agents --<br/>Ocular pharmacology --<br/>Dermatological pharmacology --<br/>Contraception and pharmacotherapy of obsterical and gynecological disorders --<br/>Environmental toxicology; carcinogens and heavy metals --<br/>Appendix I: Principles of prescription order writing and patient compliance --<br/>Appendix II: Design and optimization of dosage regimens: pharmacokinetic data |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc |
The "Harrison's of Pharmacology" -- now in full color |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Pharmacology. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Therapeutics. |
| 650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Pharmacological Phenomena. |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Drug Therapy. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Goodman, Louis S. |
| Fuller form of name |
(Louis Sanford), |
| Dates associated with a name |
1906-2000. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Brunton, Laurence L. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Chabner, Bruce. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Knollmann, Björn C. |
| 730 0# - ADDED ENTRY--UNIFORM TITLE |
|---|
| Uniform title |
Goodman & Gilman's the pharmacological basis of therapeutics. |
| 856 ## - ELECTRONIC LOCATION AND ACCESS |
|---|
| Materials specified |
Abstract |
| Uniform Resource Identifier |
<a href="http://repository.fue.edu.eg/xmlui/handle/123456789/1653">http://repository.fue.edu.eg/xmlui/handle/123456789/1653</a> |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Koha item type |
Books |
| Source of classification or shelving scheme |
Dewey Decimal Classification |